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Tumor formationGlycosylation plays a role in regulating many biological activities, including protein folding and cell surface
expression of biomolecules. However, the importance of glycosylation for KCC4 function has not previously
been demonstrated. Site-directed mutagenesis was performed on the four putative extracellular N-linked
glycosylation sites of KCC4 to determine the role of these sites in KCC4 half-life, cell surface expression,
and transporter activity, as well as in KCC4-dependent tumor formation. We showed that triple (N312/
331/344/Q) and quadruple (N312/331/344/360/Q) mutations of N-linked glycosylation sites disrupt the
N-linked glycosylation of KCC4, resulting in the accumulation of KCC4, predominantly in the endoplasmic re-
ticulum (ER) and not at the cell surface. Further investigation indicated that mutations of the central two
(N331/344/Q) N-linked glycosylation sites inhibit the membrane trafﬁcking of KCC4. Our data suggest that
the glycan moieties at the N331 and N344 sites were Endo H-resistant, complex-form structures, and that
the N312 and N360 sites were Endo H-sensitive, high mannose-containing structures. Under hypotonic stress
conditions, the ability to adapt to changes in intracellular chloride ion concentrations and RVD (regulatory
volume decrease) activities were less efﬁcient in cells containing the deglycosylated form of KCC4 that
were not expressed at the cell surface. Deglycosylated forms of KCC4 also demonstrated decreased tumor for-
mation and lung colonization in mouse xenografts. The difference in glycan complexity may account for the
differential impact of each branch on the biological effects of KCC4. We propose that glycosylation is essential
for the surface expression, stabilization, and bioactivity of KCC4.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Glycosylation, which involves the enzyme-controlled addition of a
sugar moiety to a protein, is the most common type of post-
translational modiﬁcation. The sugar chain can link either to the amino
(\NH2) group of asparagine (referred to as “N-linked” glycosylation)
or to the \OH group of serine or threonine (“O-linked” glycosylation).
Glycosylation is involved in many important biological processes [1,2],
including cell–cell adhesion, trafﬁcking [3], and protein stability, but
the role of glycosylation in these activities is not well understood.
N-linked glycosylation occurs in the endoplasmic reticulum (ER) with
the addition of high-mannose sugars, and these glycan moieties areynecology, College of Medicine,
, Taiwan. Tel.: +886 6 2353535
ou).
rights reserved.further processed into complex-form glycans in the Golgi [4]. This pro-
cess increases the apical surface expression and stability [5,6] and alters
the function [7] of the target protein. N-linked glycoproteins are also
involved in the progression of certain cancers [7]. Moreover, N-linked
glycosylation inhibitors have been shown to have potential in the devel-
opment of novel therapeutic approaches for cancer therapy [8].
Originally described in red blood cells, K+Cl− cotransporters (KCCs)
belong to the SLC12 family and act as electroneutral symporters of K+
and Cl− ions across the plasma membrane [9]. K+Cl− cotransport,
which can be activated by cell swelling, is necessary for the regulation
of cell volume, the transepithelial transport of ions, and the mainte-
nance of intracellular Cl− concentration [10]. Four isoforms of KCC
have been identiﬁed: KCC1, KCC2, KCC3, and KCC4.
In addition to being major determinants of osmotic homeostasis,
KCCs are also emerging players in the ﬁeld of tumor biology [11,12].
The malignant transformation of uterine cervical epithelial cells has
been associated with the differential expression of volume-sensitive
KCC isoforms [13]. A loss-of-function KCC mutant in cervical cancer
cells was found to inhibit cell growth and decrease the activities of
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insulin-like growth factor-1 (IGF-1) upregulates KCC3 and KCC4,
which are differentially required for cancer cell proliferation and in-
vasiveness [14]. Overexpression of KCC3 downregulates E-cadherin/
β-catenin complex formation by inhibiting the transcription of the
E-cadherin gene and accelerating the proteasome-dependent degra-
dation of the β-catenin protein, promoting the epithelial–mesenchy-
mal transition [15]. Moreover, epidermal growth factor (EGF) and
IGF-1 stimulate the membrane recruitment of KCC4 at lamellipodia
through the myosin Va-actin trafﬁcking route [16]. KCC4 functions
as a membrane scaffold for the assembly of signaling complexes via
the association with the actin-binding protein ezrin [16]. Molecular
studies of surgical specimens show that greater KCC4 expression in
tumor tissues is associated with a higher risk of tumor metastasis
and cancer recurrence [16]. Taken together, these ﬁndings suggest
that KCCs (KCC3 and KCC4 in particular) can be used as biomarkers
to predict outcomes in cancer patients.
The four KCC isoforms share a common protein structure with a
central core of twelve hydrophobic transmembrane domains [17,18].
Protein structure prediction analysis suggests that the 4 N-linked glyco-
sylation sites are conserved and are found in the outer loop between the
5th and 6th transmembrane segments of KCC4. Our previous ﬁndings
demonstrated that motor protein-dependent membrane trafﬁcking of
KCC4 is important for cancer cell invasion [16]. This study sought to in-
vestigate the role of N-linked glycosylation in the localization, protein
stability, and activity of KCC4.2. Materials and methods
2.1. Cell culture and reagents
The AD-293 cell line is a more adherent derivative of HEK293 cells
(Stratagene, La Jolla, CA), and the AS-2 cell line is a lung adenocarci-
noma cell line [19]. AS-2 stable clones were selected with blasticidin
following transfection with various KCC4 constructs. Cell growth
was determined by thiazolyl blue tetrazolium bromide (MTT)
(Sigma, St Louis, MO) assay in 96-well plates. To analyze protein sta-
bility, cycloheximide (20 μg/ml) was added to AD-293 cells that had
been transfected with different KCC4 constructs and cell lysates
were collected at the indicated time points. For the analysis of KCC4
degradation, the proteasome inhibitor MG132 (Sigma), the lysosome
inhibitors NH4Cl and leupeptin (Sigma), and a protease inhibitor
cocktail tablet (Roche, Grenzacherstrasse, Basel) were incubated
with cells for 6 h, and the lysates were then collected.2.2. Plasmid constructs
Full-length mouse KCC4 harboring an exogenous V5 (referred to
here as KCC4wt) was constructed by cloning pXT7–mKCC4 into the
pCDNA6/V5-His vector (Invitrogen, Grand Island, NY). Three mouse
KCC4 N-linked glycosylation mutant constructs (kindly provided by
Dr. David B. Mount) were obtained, in which asparagine (N) was re-
placed with the amino acid glutamine (Q) to block N-linked glycosyla-
tion of mouse KCC4. These mutant constructs included the following:
pGEMHE-double (N312/331/Q), pGEMHE-triple (N312/331/344/Q),
and pGEMHE-quadruple (N312/331/344/360/Q). These 3 constructs
were subcloned from thepGEMHEoocyte system into amammalian ex-
pression system (pCDNA6/V5-His)with a V5 tag to differentiate endog-
enous KCC4 from exogenous KCC4 mutants (referred to here as M II,
M III, and M IV). All sequences of newly constructed clones used in
this study were conﬁrmed by sequencing. Arrest-In reagent (Thermo
Scientiﬁc, Rockford, IL) or Lipofectamine 2000 reagent (Invitrogen)
was used for plasmid DNA transfections, which were carried out
according to the manufacturers' protocols.2.3. Site-directed mutagenesis
AQuikChange®Site-DirectedMutagenesis kit (Stratagene)was used
to generate the N344/Q and N360/Q point-mutant constructs, using the
KCC4wt construct containing the V5 tag as a template. The primers used
were as follows (only forward primers are listed): 331 mutant primer:
5′'-GATGCAGGTTGTCAGCCAGGGTACAGTGACCACTG-3′; 344 mutant
primer, 5′-GGCGCCTCTTCTGCCAGGGCTCCAGCTTGGG-3′; and 360 mu-
tant primer, 5′-TGAGTACTTTGCACAGAACCAGGTTACTGAGATACAGGG
CA-3′. The N344/360/Q mutation was generated using the 360 mutant
primer and the N344/Q mutant construct as a template. N312/331/
360/Q was generated using the 360 mutant primer and the M II con-
struct as a template. N331/344/Q was generated using the 331 mutant
primer and the N344/Q construct as a template. Procedures were
conducted according to the manufacturer's protocol. In brief, the tem-
plate, primers, and dNTPs were mixed with PfuTurboDNA polymerase
and subjected to PCR using the following protocol: 95 °C for 30 s
(1 cycle), 95 °C for 30 s, 55 °C for 1 min, 68 °C for 9.5 min (18 cycles),
and ﬁnally, 68 °C for 9.5 min (1 cycle). DpnI was added, and the reac-
tions were incubated in a 37 °C water bath for 1.5 h. Positive clones
were veriﬁed by sequencing.
2.4. Glycosidase assay
The cells were lysed in radioimmunoprecipitation (RIPA) buffer, and
20 μg of protein was used in each reaction. The protein was thenmixed
with glycoprotein denaturing buffer (New England Biolabs, Ipswich,
MA) and incubated at 100 °C for 10 min. For endoglycosidase H and
peptide N-glycosidase F (New England Biolabs) digestions, the appro-
priate buffer was added to the whole cell lysates according to the
manufacturer's instructions, and the reactions were incubated in a
37 °C water bath for 1.5 h.
2.5. Western blotting
The cells were lysed with either RIPA or sample buffer and then
harvested using a cell lifter (Costar, New York, NY). Protein concen-
trations were determined using the Bio-Rad protein assay. Proteins
were then separated by 6% or 12% SDS-PAGE and transferred to
polyvinylidene diﬂuoride membranes. Antibodies used in this study
included the following: anti-V5 antibody (Invitrogen), anti-mKCC4
antibody (kindly provided by Dr. David B. Mount), and anti-beta
actin antibody (Sigma).
2.6. Immunoﬂuorescence
The cellswere seeded and transfected in chamber slides (NalgeNunc,
Rochester, NY) for 48 h. The cells were then ﬁxed in 3.7% paraformalde-
hyde, washed, and incubated in 0.05% Triton-X100 for 15 min. Next, the
cells were blocked with SuperBlock solution (Thermo Scientiﬁc) for 1 h
at room temperature. Primary antibodies were incubated with cells at
4 °C overnight followed by TBST wash, and the appropriate secondary
antibody (anti-mouse Alexa-488, anti-mouse Alexa-594 or anti-rabbit
Alexa-594 (Molecular Probes, Eugene, OR)) and Hoechst 33342 dye
were incubated with the cells for 1 h in the dark. Slides were then
washed and ﬁxed with GG1 gel (Sigma). Confocal imaging was
conducted using a FV1000 microscope (Olympus, Tokyo, Japan). Anti-
bodies used for the immunoﬂuorescence imaging included the follow-
ing: anti-V5 antibody (Invitrogen), anti-calnexin antibody (Abcam, San
Francisco, CA), anti-mannosidase II antibody (Chemicon, Darmstadt,
Germany), and anti-NKCC1 antibody (Santa Cruz, Delaware Avenue, CA).
2.7. Cell surface botinylation
Cell membrane proteins were isolated by cell surface protein isola-
tion kit (Pierce Biotechnology, Rockford, IL). Brieﬂy, cells were grown
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NHS-SS-Biotin at 4 °C for 30 min. Biotinylation was inhibited by
treating cells with Quenching solution prior to cell lysis. For isolationA
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Fig. 2. KCC4wt and M II colocalize with the cell membrane, whereas M III and M IV are retained in the ER. Representative confocal images of AD-293 cells transiently transfected with
wild-type and mutated KCC4 proteins, detected by immunostaining for the V5 tag. To verify cell membrane or ER localization, constructs were (A) costained with an endogenous
membrane marker NKCC1 and (B) the ERmarker calnexin, or (C) Golgi marker mannosidase II. Staining of KCC4wt andM II extended to the cell membrane border, whereas M III and
M IV exhibited perinuclear staining and colocalization with calnexin. The mannosidase II stains were conﬁned in the high mannose-containing mutants and deglycosylated M IV.
(Man II: Mannosidase II) (D) AD-293 cells were stably cloned with KCC4wt, M III, and M IV. Cells were treated with biotin to label surface protein. Total cell lysate and NeutrAvidin
Agarose pull-down lysate were immunoblotted with an anti-V5 antibody. Antibody against actin was used as the control.
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Intracellular chloride concentration was measured under hypotonic
stress by cotransfecting the ﬂuorescence resonance energy transfer
(FRET) plasmid Clomeleon with mock, KCC4wt or M IV plasmids into
AD-293 cells. Clomeleon (kindly provided by Dr. Thomas Kuner) en-
codes a CFP–YFP fusion protein, for which the ﬂuorescent emission
peak of the CFP overlaps the excitation peak of the YFP. The emission
of YFP is quenched by chloride ions; therefore, the efﬁciency of FRET be-
tween these chromophores inversely correlates with chloride concen-
tration [20]. Forty-eight hours following the cotransfections, the cellswere treated with an isotonic buffer containing chloride and a
chloride-free hypotonic buffer for 10 min. Cells treated with chloride-
free isotonic buffer and chloride-free hypotonic buffer represented the
maximal emission FRET ratio. The cells were then ﬁxed with 3.7% para-
formaldehyde and mounted with GG1 gel. The images were captured,
and FRET ratios were determined using a FV1000 confocal microscope
(Olympus). Isotonic buffer with Cl− contained 150 mM NaCl, 5 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES (pH=7.4, titrated
by Tris). Isotonic buffer without Cl− contained 150 mM Na-gluconate,
5 mM K-gluconate, 5 mM Ca-gluconate, 1 mM Mg-gluconate, and
10 mM HEPES (pH=7.4, titrated by Tris). Finally, hypotonic buffer
AB
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1139T.-Y. Weng et al. / Biochimica et Biophysica Acta 1833 (2013) 1133–1146without Cl− contained 80 mMNa-gluconate, 5 mMK-gluconate, 5 mM
Ca-gluconate, 1 mM Mg-gluconate, and 10 mM HEPES (pH=7.4,
titrated by Tris).
2.9. Regulatory volume decrease
Isotonic buffer (osmolarity=300 mOsmol/l) contained 100 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 1.5 mM CaCl2, 10 mM Glucose, 10 mM
HEPES, 70 mM Mannitol, pH=7.4. Hypotonic buffer (osmolarity=
230 mOsmol/l) contained 100 mM NaCl, 5 mM KCl, 1 mM MgCl2,
1.5 mM CaCl2, 10 mM Glucose, 10 mM HEPES, pH=7.4. The cells
were resuspended in the isotonic buffer, and FSC of the cells was deter-
mined by FACS using the FACSCalibur (BD, Franklin Lakes, NJ). To mon-
itor volume change during osmotic stress, cells that had been
resuspended in the hypotonic buffer were incubated in a separate
tube and analyzed by FACS to determine the FSC of the cells at the indi-
cated time point. A total of 104 cells were analyzed using identical laser
intensities. The data were analyzed using histograms, with gates set at
50% of the population of each isotonic solution to determine the stan-
dard condition. The median intensity shift for each population com-
pared with its standard condition was used to determine the changes
in cell volume (hypotonic condition minus isotonic condition).
2.10. Colony formation and animal experiments
Lower agar (0.6%)was cooled and solidiﬁed in 6-well plates at room
temperature. For upper agar, 0.3% agar containing 5×104 cells was
added to the base agar and incubated in a 37 °C incubator. Colonies
>2 mm were counted under a microscope. AS-2 cells were injected
into NOD/SCID mice via subcutaneous or intravenous route. Mice
were maintained in the NCKU Laboratory Animal Center in a day/
night cycle facility and were sacriﬁced at indicated time points. All ani-
mal studies were approved by the Institutional Animal Care and Use
Committee at National Cheng Kung University.
2.11. Statistical analysis
Values in this study are represented as the means±standard devi-
ation (s.d.). Student's t test was used for statistical analyses.
3. Results
3.1. Mutations at 4 N-linked glycosylation sites change the glycoprotein
structure of KCC4
KCC4 is a glycoprotein with 12 transmembrane domains and 4 pu-
tative N-linked glycosylation sites in its largest outer loop, at amino
acid residues 312, 331, 344, and 360 (Fig. 1A). To explore how glyco-
sylation modulates KCC4 function, serial mutant constructs of KCC4's
N-linked glycosylation sites were generated by replacing each glyco-
sylation site Asn (N) with Gln (Q). The mutant constructs of glycosyl-
ation included double (N312/331/Q), triple (N312/331/344/Q), and
quadruple (N312/331/344/360/Q) mutants (Fig. 1A). For clarity, the
double, triple and quadruple mutants are herein referred to as M II,
M III, and M IV, respectively. Following transfection of AD-293 cells
with the KCC4 mutant constructs, immunoblot analysis on whole
cell lysates was performed. In cells transfected with KCC4wt, or the
M II mutant, two protein bands were visible: a lower band, near
100 kDa, and an upper band, near 130 kDa. In contrast, only a lower
band was observed in cells transfected with the M III or M IV mutantFig. 3. Combinations of KCC4 N-linked glycosylation mutations. (A) Schematic model of diffe
N344/Q, N360/Q, N344/360/Q, N331/344/Q, and N312/331/360/Q. (B) AD-293 cells were tran
SDS-PAGE and immunoblotting with an anti-V5 antibody or by (C) treating the cells with glyc
cubated with (+) or without (−) PNGase F or Endo H. All molecular forms are sensitive to PN(Fig. 1B). The lower band of KCC4wt, M II and M III may represent
the core-glycosylated form of KCC4, located in the ER, whereas the
upper band likely represents the complex glycosylated form of
KCC4, located in the plasma membrane (Fig. 1B) [21]. Glycosidase
was then used to further distinguish the different glycan structures
of these mutants. Peptide N-glycosidase F (PNGase F) cleaves all
N-linked structures from asparagine, whereas endoglycosidase H
(Endo H) cleaves only the high-mannose structure or hybrid struc-
tures of N-linked branches (herein referred to as high-mannose
containing structures). We found that KCC4wt, M II and M III were
sensitive to PNGase F, as evidenced by the downward shift of the
upper band following PNGase F treatment. Under Endo H digestion,
a slight downward shift of the lower band of KCC4wt and M II was
detected, whereas the upper bands for each of these mutants
remained unchanged. Endo H treatment also caused the cleavage of
M III. M IV to be insensitive to both PNGase F and Endo H, suggesting
that M IV did not contain N-glycans (Fig. 1C). Taken together, these
results suggest that KCC4wt and M II contain complex-form and
high-mannose N-linked structures, whereas M III contains only high
mannose-containing structures.3.2. M III and M IV mutants are not expressed at the cell surface
Glycosylation is known to be important for protein transport. The
differences in the molecular patterns detected in the immunoblots
and the glycan structures among these KCC4 mutants led us to investi-
gatewhether alteredN-linked glycosylation impairs cell surface expres-
sion of KCC4. AD-293 cells transfected with themutant constructs were
ﬁrst analyzed using confocal immunoﬂuorescencemicroscopy to exam-
ine KCC4 localization. The majority of the KCC4wt- and M II-transfected
cells demonstrated KCC4 immunostaining at the cell membrane,
whereas immunostaining of KCC4 in the M III- and M IV-transfected
cells occurred largely in the juxta-nuclear area. To conﬁrm the localiza-
tion of KCC4 in these cell lines, we used an endogenous membrane
marker NKCC1 to verify membrane expression. As demonstrated in
Fig. 2A, V5 staining in KCC4wt andM II colocalizedwith NKCC1, whereas
V5 staining in M III and M IV did not. To further conﬁrm these results,
pAcGFP1-Mem (which encodes the N-terminus of neuromodulin
fused to GFP and demonstrates strong labeling at the cell membrane)
was transfected into AD-293 cells, and similar results were obtained
(Supplementary Fig. 1). pAcGFP1-Endo, which encodes a RhoB gene
fused to GFP, was transfected into the AD-293 cells; RhoB is largely
expressed in late endosomes, the cell membrane, and nuclear margins.
Colocalization of KCC4-V5 and RhoB-GFP was observed in KCC4wt and
M II at the cell surface, whereas cells transfected with M III and M IV
displayed a perinuclear, ER-like staining pattern (Supplementary
Fig. 2). Because a perinuclear pattern is a hallmark of ER-resident pro-
teins, we next tested whether KCC4 in M III and M IV colocalized with
the ER marker calnexin. KCC4 and calnexin colocalized (Fig. 2B), indi-
cating that KCC4 in M III and M IV failed to exit in the ER and in turn
was not expressed at the cell surface. A Golgi marker, mannosidase II,
was used and further conﬁrmed that M III and M IV were arrested in
the ER and Golgi (Fig. 2C). In a surface biotinylation experiment, only
the upper band of KCC4wt was labeled with biotin, as shown in the
NeutrAvidin Agarose pull-down lane, but not the lower band
(Fig. 2D). This result further suggested that the upper band is the
complex-form structure (Fig. 1C) that can reach the cell membrane.
No biotin-labeled protein of M III and M IV was observed, which indi-
cated that M III and M IV were not expressed in the cell membrane.rent N-linked glycosylation mutations generated by site-directed mutagenesis, including
siently transfected with constructs listed in (A), and whole cell lysates were analyzed by
osidase, followed by immunoblotting with an anti-V5 antibody. Total cell lysates were in-
Gase F, whereas the N331/344/Q mutant is uniquely sensitive to Endo H.
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membrane expression
Because KCC4 in M III (but not M II) failed to localize to the cell
membrane, we hypothesized that the N344 glycosylation site is impor-
tant for KCC4membrane expression. To investigate this hypothesis, weFig. 4. Mutations at the central two N-linked glycosylation sites of KCC4 alter KCC4 cel
transfected with wild-type and mutated KCC4 proteins, detected by immunostaining for t
the membrane marker NKCC1 to verify cell membrane expression. Immunostaining of N34
331/360/Q partially localized to the cell membrane marker, whereas N331/344/Q largely
arrowheads.performed site-directed mutagenesis to generate additional mutant
constructs, as shown in Fig. 3A. Immunoblot analysis revealed that, as
with the immunoblot patterns for KCC4wt and M II, the N344/Q and
N360/Q mutants exhibited two protein bands (Fig. 3B). Glycosidase
analysis further demonstrated that the major band of N344/Q and
N360/Qwere sensitive to PNGase F and insensitive to Endo H treatmentl membrane expression. Representative confocal images of AD-293 cells transiently
he V5 tag. KCC4wt or mutant constructs were costained with an anti-V5 antibody and
4/Q and N360/Q was observed at the cell membrane border. N344/360/Q and N312/
localized to the intracellular compartment. Colocalization of proteins is denoted by
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glycan structures. Immunoﬂuorescence analysis showed that KCC4 in
the N344/Q and N360/Q mutants was expressed at the cell membrane
and colocalized with NKCC1 (Fig. 4). This ﬁnding suggests that it is
not sufﬁcient for a single N344/Q or N360/Qmutations to impair mem-
brane expression of KCC4. To further investigate this hypothesis, N344/
360/Q, N331/344/Q, and N312/331/360/Q mutants were constructed.
Immunoblot analysis revealed only a lower protein band in N331/
344/Q. Intriguingly, the N344/360/Q and N312/331/360/Q mutants
displayed two protein bands, whose positions in the immunoblots
were substantially lower and more variable than those observed for
the KCC4wt and M II mutants (Fig. 3B). Glycosidase treatment demon-
strated that N331/344/Q (harboring the central two mutations) was
sensitive to PNGase F and Endo H, suggesting the presence of a highIso
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Fig. 6. M IV exhibited a lower capacity for ﬂuctuations in intracellular chloride ion concen
mock, KCC4wt, or M IV plasmids. FRET ratios were higher following hypotonic stress in ea
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mock-transfected cells.mannose-containing structure (Fig. 3B). N344/360/Q and N312/331/
360/Q mutants were sensitive to both PNGase F and Endo H, with the
upper band being insensitive to Endo H, indicating that KCC4 in these
two mutants contained a complex-form structure, albeit a structure
that was different from that of KCC4wt (Fig. 3C). Immunoﬂuorescence
microscopy demonstrated that V5 staining in N331/344/Q did not
colocalize with NKCC1, indicating that the cell surface expression of
this mutant was impaired (Fig. 4). Further analysis with calnexin fur-
ther indicated that N331/344/Qwas retained in the ER (Supplementary
Fig. 5B). No biotin-labeled protein of N331/344/Q was observed, which
indicated that N331/344/Q was not expressed in the cell membrane
(Supplementary Fig. 5C). In N344/360/Q and N312/331/360/Qmutants,
only a few scattered colocalizations of KCC4with NKCC1were observed
(Fig. 4). Similar results were obtained using pAcGFP1-Mem for cellAS-2 Mock
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VD ability under hypotonic stress is less efﬁcient in AS-2 cells transfected with the M
reduced MTT activities and (D) were less efﬁcient at colony formation compared to
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gest that the central two N-linked glycosylation sites are critical for
KCC4 membrane expression.3.4. The high-mannose form of N-glycan is degraded through the
proteasome pathway
Glycan structures play an important role in protein stability. We
were interested in determining whether KCC4 protein stability is af-
fected by the presence of its N-linked glycan motifs. Cycloheximide,
an inhibitor of protein synthesis, was used to test the rate of KCC4
protein degradation. We found that the complex-forms of KCC4wt
and M II (upper band of M II, Fig. 5A) have a longer half-life than
the high mannose-containing forms in KCC4wt, M II and M III, indicat-
ing that complex-form glycans augment the stability of KCC4 (Fig. 5A,
B). Because protein stability is reduced in the high-mannose form, we
next investigated the major route of KCC4 degradation, namely, the
proteasome, lysosome, and protease pathways of protein degrada-
tion, using inhibitors speciﬁc for each degradation pathway. Fig. 5C250
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immunostaining in KCC4WT tumors (400×). (D) Immunoblot analysis of the V5 tag in subcutashows that, following treatment with MG132 (a speciﬁc inhibitor of
the proteasome pathway), more high-mannose forms were present,
accompanied by the attenuation of the complex-form. No signiﬁcant
change was observed using the lysosome inhibitors (NH4Cl, Fig. 5C;
Leupeptin, Supplementary Fig. 4) or protease inhibitor (Fig. 5C).
Therefore, the proteasome pathway is the major protein degradation
pathway involved in the degradation of KCC4, particularly in regard
to the high-mannose form.3.5. M IV and N331/344/Q mutants suppress KCC4-mediated RVD and
tumor formation
Our previous studies demonstrated that membrane trafﬁcking and
cell surface expression of KCC4 are important for cancer cell invasion
[16]. Because M III and M IV were not expressed at the cell surface, we
postulated that KCC4 function could also be affected by thesemutations.
First, M IV was used for the functional study. To test whether glycosyl-
ation is important for KCC4 cotransporter function, Clomeleon and
mock, KCC4wt or M IV plasmids were transiently transfected into16 17
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hypotonic stress for 10 min. The gluconate solution, which is chloride-
free and therefore represents the maximal emission FRET ratio, served
as the positive control. Under hypotonic stress conditions, the degree
of intracellular chloride change was signiﬁcantly reduced in cells
transfected with M IV compared with that of the mock-transfected or
KCC4wt-transfected cells (Fig. 6A). To examine the role of KCC4 glyco-
sylation in cell volume regulation, we compared the regulatory volume
decrease (RVD) process in mock and M IV mutant stably transfected
lung cancer AS-2 cells, M IV-1 andM IV-2. Forward scatter (FSC) repre-
sents the cell volume under speciﬁc laser intensity, and the percent vol-
ume changewas calculated using equivalent laser intensities. As shown
in Fig. 6B, the typical volume response of AS-2 cells to hypotonic solu-
tion can be divided into three phases: (1) an initial, rapid cell swelling
to reach a peak cell volume; (2) subsequent cell shrinkage; (3) and ﬁ-
nally, a more gradual decrease in cell volume that eventually plateaus.
AS-2 cells expressing the M IV mutation exhibited an increase in initial
cell swelling, attenuated cell shrinkage, and an inhibition in the charac-
teristic gradual decrease in cell volume, indicating that cells harboringthe M IV mutation have a lower capacity for cell volume regulation
compared to mock-transfected cells.
We next examined whether deglycosylated KCC4 could affect cell
biology. MTT assays and colony formation experiments demonstrated
that M IV-expressing AS-2 cells were less viable and less able to form
colonies compared with mock-transfected cells (Fig. 6C, D). To test
whether manipulation of KCC4 glycosylation alters tumor growth and
lung colonization, we inoculated NOD/SCID mice subcutaneously or in-
travenously with KCC4 mock or M IV-expressing AS-2 cells. Rapid
tumor growth in terms of subcutaneous tumor (Fig. 7A) or lung tumor
nodules (Fig. 7B) was obvious in the groups inoculated with the KCC4
mock-expressing AS-2 cancer cells. The M IV glycosylation mutation
signiﬁcantly reduced the rate of tumor formation and decreased the
tumor size in the dermis and the number of tumor nodules in the
lungs. Consistent with the in vitro immunoﬂuorescence study, the his-
tology of subcutaneous tumors resulting from inoculation of M IV mu-
tants exhibited predominantly cytoplasmic or perinuclear staining of
KCC4-V5, which was in contrast to the membrane staining in the
KCC4wt (Fig. 7C). Immunoblots further conﬁrmed the presence of the
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Fig. 8.Mutation of the central two glycan branches reduced the RVD ability and tumor
formation. (A) AS-2 cells transfected with N360/Q construct did not abrogate the RVD
activities of KCC4. Similar to AS-2 M IV-1 cells, AS-2 cells transfected with central
mutation (central mutation: CM, N331/344/Q) construct demonstrated reduced RVD
activities under hypotonic stress compared with AS-2 mock cells (n=4). (B) Tumor
growth curves of SCID mice subcutaneously injected with AS-2 mock, AS-2 N360/Q,
AS-2 CM, and AS-2 M IV-1 cells (n=6–8). Mice were sacriﬁced 15 days following
tumor transplantation. Representative tumor xenografts are shown.
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ation plays an important role in tumor formation and lung colonization.
To further investigate whether delivery of KCC4 at the cell surface
affects its bioactivities, N360/Q and N331/344/Q (central mutation:
CM) mutants were used in this study. These two constructs were sta-
bly transfected in the AS-2 cells. The abilities to adapt to osmotic chal-
lenge and tumor formation in N360/Q-expressing AS-2 cells were not
affected, as compared with the mock-containing AS-2 cells. In con-
trast, AS-2 cells expressing the central mutation exhibited signiﬁcant-
ly less efﬁcient RVD activities and showed a reduced rate and size of
tumor formation, which resembled the impaired KCC4 bioactivities
in AS-2 M IV-1 cells (Fig. 8A, B).
4. Discussion
We investigated the importance of the four N-linked glycosylation
sites in the large extracellular loop between the 5th and 6th trans-
membrane domains of KCC4 in cell membrane expression and protein
stability as well as in various functions of KCC4, including cell volume
regulation, cell proliferation, tumor growth, and tumor progression.
The principal ﬁnding of our study was that the localization of KCC4
to the cell surface depends on the central two N-linked glycosylation
sites located at amino acid residues 331 and 344 of KCC4. Our results
also suggest that glycan structure (i.e., the presence of complex-form
glycans) is the major determinant of the cell surface expression of
KCC4, and that surface expression of KCC4 plays an important role
in its bioactivities. Additionally, we found that N-linked glycosylationplays a role in maintaining protein stability and in regulating
KCC4-mediated functions, such as the regulation of cell volume,
anchorage-independent cell growth, tumor formation, and lung colo-
nization by tumors. It would be interesting to investigate whether
N-linked glycosylation plays similar roles in other KCCs that share a
common protein structure with KCC4.
Many previous studies have demonstrated that complex-form gly-
cans are mature and functional proteins, whereas the high-mannose
form is core-glycosylated and is retained in the ER [3,5,21]. The func-
tional differences between complex and high-mannose structures are
rooted in the structural differences (such as the accessibility of amphi-
philic or hydrophobic domains) that facilitate or inhibit interactions
with other proteins; for example, high-mannose N-glycans can pro-
mote protein folding, whereas complex-form N-glycans contribute to
protein stability [22]. Based on our results, which were obtained using
a combination of approaches, we propose that glycosylation sites
N312 and N360 are high mannose-containing structures, and that
N331 and N344 are complex-form structures (Supplementary Fig. 5A).
Moreover, we suggest that N344 contains a larger ormore complex gly-
can branch than does N331, because the position of the N312/331/360/
Q protein band in the immunoblot analysis was higher than the band
from N344/360/Q (Fig. 3B). In both N344/360/Q and N312/331/360/Q
mutants, small scattered expression of KCC4 can be detected in the
cell membrane by confocal imaging. As a result, we suggest that N344
and N331 residues are critical for cell surface expression, and mutation
of either residue alone is not sufﬁcient to completely abrogate the traf-
ﬁcking of KCC4 to the cell membrane. We also found that M III is sensi-
tive to Endo H treatment, suggesting that residue 360 harbors a high
mannose-containing structure. Mutation at the central two sites
(N331/344/Q) causes KCC4 to be retained in the ER and renders KCC4
sensitive to both PNGase F and Endo H, suggesting the existence of
the high-mannose form structures. This ﬁnding also suggests that the
glycosylation site at residue 312 of KCC4 contains the high-mannose
form structure. M II contains both complex-forms and high-mannose
forms, which were identiﬁed by glycosidase treatment and immuno-
blotting (Fig. 1C). These ﬁndings, along with the results from the
N344/Q, N360/Q, N344/360/Q, and N312/331/360/Q mutants, further
suggest that N344/Q and N360/Q contain complex-form glycan struc-
tures. Collectively, our results demonstrate that the complex-form
N-linked glycan is the fully glycosylated form of KCC4, which is
expressed at the cell surface. In contrast, the high-mannose form is
likely the less mature glycan that is retained in ER and may be more
quickly degraded by the proteasome.
N-linked glycosylation is involved in cell surface expression of potas-
sium channels [6,23]. Disruption of N-linked glycosylation reduces the
apical expression of proteins [6,24,25]. Our ﬁndings are consistent
with these observations, and further demonstrate that the central two
N-linked glycosylation sites of KCC4 are the major determinants of
KCC4 cell membrane expression. The importance of the central two
N-linked sites for KCC4 expression might result from structural differ-
ences in the protein near these residues or fromdifferences in the acces-
sibility of the N-glycans at their distinct locations in the protein. The
process of converting a high-mannose form structure into a complex-
form glycan in the Golgi has been reported to improve the apical surface
expression of glycoproteins [3,5,6]. Consistent with these ﬁndings, our
results demonstrate that complex-form N-glycans (such as those
contained in the N331 and N344 sites of KCC4) can reach the cell
surface; indeed, the N331 and N344 mutants in this study were more
likely to be retained in the cytoplasm, possibly due to being targeted
by the ER quality control system. In contrast, high mannose-containing
structures, such as the N312 and N360 sites, play less important roles
in cell surface expression of KCC4.
The KCC1-ΔN117 mutant construct, which harbors a truncation of
the ﬁrst 117 amino acids in the N-terminus of KCC1, but retains an in-
tact N-linked glycan, is a loss-of-function variant of pan-KCCs [26].
KCC1-ΔN117 can be expressed at the cell membrane in the oocyte
1146 T.-Y. Weng et al. / Biochimica et Biophysica Acta 1833 (2013) 1133–1146system [26], which indicates that the ﬁrst 117 amino acids of KCC1
N-terminus are not required for its cell surface expression. However,
mutation of the cysteine residues in the large outer loop does not im-
pair membrane expression of KCC4 or a KCC2–KCC4 chimera [27].
This indicates that different regions of the KCC4 protein may be in-
volved in different processes.
Our previous studies have highlighted the importance of KCC4 in
tumor development and progression. KCC4 functions as a membrane
scaffold which facilitates the cytoskeletal reorganization required for
cellular invasiveness [16]. KCC4-mediated cancer cell invasion and
metastasis may be due to greater cell motility, adhesion and migra-
tion, as well as increased MMP activation, which is important for can-
cer invasiveness [28]. Furthermore, KCC4 plays a role as a plasma
membrane scaffold, which may regulate the integrity of the cytoskel-
eton. The present study demonstrates the role of N-linked glycosyla-
tion in KCC4-regulated cell volume regulation and tumor biology, and
provides further evidence that N-linked glycosylation is required for
KCC4-regulated tumor behavior (such as tumor formation and lung
colonization by cancer cells). Disruption of N-linked glycosylation in
proteins, such as KCC4, disrupts proper cell volume regulation, and
the activity of cancer cells. Additionally, deglycosylation may induce
apoptosis in glioma and prostate cancer cells [29,30]. Additional stud-
ies are required to better understand the precise mechanisms of
N-linked glycosylation in tumor biology with a view to possibly
develope novel therapies using N-linked glycan inhibitors.
In conclusion, our data reveal an important role for the central two
N-linked glycosylation sites in cell membrane expression and activity
of KCC4. Furthermore, our study demonstrates strong relationships of
N-linked glycosylation with protein stability and osmotic homeosta-
sis, and it highlights the important role of N-linked glycosylation in
KCC4-mediated tumor behavior. These ﬁndings offer additional in-
sight into the glycan structure and function of KCCs, and potentially
suggest that future cancer therapies involving inhibition of KCC4 re-
cruitment to the cell membrane or inhibition of N-linked glycosyla-
tion in KCC4-abundant cancer cells could be developed.
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